⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL697502 | 0.77 | — | — | |
| SCHEMBL32691219 | 0.74 | — | — | |
| SCHEMBL25022536 | 0.73 | — | — | |
| SCHEMBL16325172 | 0.70 | — | — | |
| SCHEMBL3007386 | 0.69 | — | — | |
| SCHEMBL16486220 | 0.68 | — | — | |
| SCHEMBL6589727 | 0.68 | — | — | |
| SCHEMBL16577414 | 0.68 | — | — | |
| SCHEMBL12462588 | 0.67 | — | — | |
| SCHEMBL1782649 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3019196-B1 | COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-06-06 | — | — | EP | disclosed |
| EP-2802326-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-04-18 | — | — | EP | disclosed |